Navigation Links
Mining bacterial genomes reveals valuable 'hidden' drugs
Date:8/1/2010

A new tool to excavate bacterial genomes that potentially hide a rich array of pharmaceutical treasures has led to the discovery of a novel antibiotic. The study, reported in the August issue of Microbiology, could lead to new treatments for serious diseases that are rapidly acquiring multi-drug resistance.

Scientists from the University of Groningen in The Netherlands successfully used a 'genome mining' approach to find and activate a group of genes in the bacterium Streptomyces coelicolor. This resulted in the production of a new antibacterial compound that was effective against several bacterial strains, including Escherichia coli.

Streptomyces is a common soil bacterium that is well-known for its antibiotic-producing capabilities. In 2002, genomic sequencing of one Streptomyces species, S. coelicolor, revealed several groups of genes whose function was unknown. By digging deeper and removing a molecule that specifically inactivates one of the mystery gene groups, known as cpk, the researchers in this study were able to 'awaken' the genes, to find that they produced the new antibiotic, in addition to a bright yellow pigment.

This is the first time a genome mining approach to drug discovery has been successfully used in Streptomyces. "The strategy is a powerful and innovative way of searching for new antibiotic production capabilities in bacteria," said Dr Eriko Takano who led the study. "As bacterial infections previously considered as mild and easily curable are suddenly becoming lethal and completely unresponsive to all existing medication, it is crucial that new antibiotics are discovered at a sufficiently rapid rate," she said.

The same approach for 'awakening' new antibiotic production pathways could also be used to tap other micro-organisms, such as filamentous fungi, for sources of biologically active compounds. Aside from antibiotics, these compounds may include other antimicrobials or antitumour agents. "There are several thousand other uncharacterized groups of genes that have been found recently in microbial genome sequences. This opens up a rich treasure trove of new potential drugs for clinical use," explained Dr Takano.


'/>"/>

Contact: Laura Udakis
l.udakis@sgm.ac.uk
44-118-988-1843
Society for General Microbiology
Source:Eurekalert  

Related biology news :

1. Sex on the brain: Doublesex gene key to determining fruit fly gender
2. Plants in mining areas can cure soil affected by contamination in very short time
3. Eminent group of scientists call for moratorium on issuance of mountaintop mining permits
4. Examining diabetes through a new lens
5. New research examining essential drugs, emerging botanicals supported by USP Awards
6. First neuroimaging study examining motor execution in children with autism reveals new insights
7. Study examining role of genetics and environment in type 1 diabetes
8. In the ring: Researchers fighting bacterial infections zero in on microorganisms soft spots
9. Bacterial diversity of Tablas de Daimiel studied for first time
10. New bacterial signaling molecule could lead to improved vaccines
11. Antibacterial silver nanoparticles are a blast
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Mining bacterial genomes reveals valuable 'hidden' drugs
(Date:3/28/2017)... , March 28, 2017 The ... Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, ... Region - Global Forecast to 2022", published by MarketsandMarkets, ... 2016 and is projected to reach USD 75.64 Billion ... and 2022. The base year considered for the study ...
(Date:3/24/2017)... 24, 2017 The Controller General of Immigration from ... Abdulla Algeen have received the prestigious international IAIR Award for the ... Continue Reading ... ... Controller Abdulla Algeen (small picture on the right) have received the IAIR ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based ... to 2022", published by MarketsandMarkets, the market is expected to be worth USD ... 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... ... 2017 , ... San Diego-based team building and cooking events company, Lajollacooks4u, has ... The bold new look is part of a transformation to increase awareness, appeal to ... period. , It will also expand its service offering from its signature gourmet cooking ...
(Date:10/10/2017)... 10, 2017 International research firm Parks Associates announced ... at the TMA 2017 Annual Meeting , October 11 in ... residential home security market and how smart safety and security products impact ... Parks Associates: Smart Home ... "The residential security market has ...
(Date:10/9/2017)... DIEGO , Oct. 9, 2017  BioTech ... biological mechanism by which its ProCell stem cell ... critical limb ischemia.  The Company, demonstrated that treatment ... amount of limbs saved as compared to standard ... the molecule HGF resulted in reduction of therapeutic ...
Breaking Biology Technology: